Companies: 10,795·Total market cap: $144.5T

PureTech Health plc

PureTech Health plc

PRTCNASDAQHealthcare● Active

$17.42

+$0.17(+0.99%)

Market Cap$424066836

P/E Ratio—

52W High$19.92

52W Low$14.5

Avg Volume9K

Open$17.44

Beta0.79

股票排行：Biotechnology·Healthcare·查看全部市值排行 →

PureTech Health plc（PRTC）股票概览

关键指标与盈利、估值、营收、股息等标签页深链。

FMP · PRTC · 截至 Jun 9, 2026

关键指标

EPS (TTM)$-26.80Earnings history

PE Ratio (TTM)—PE Ratio deep dive

Revenue (TTM)$9.0MFull revenue history

Dividend Yield不分红Dividend history

Shares Outstanding2.4MShares outstanding history

Next EarningsAug 27, 2026Est.Earnings history

探索 PureTech Health plc 数据

分析师预测$57 · Buy

股息不分红

营收$4.7M-3.50%

盈利EPS $-46.00-2400.00%

财务快照

FY 2025Revenue$4.7M▼ 3.50% YoY

202320242025

FY 2025Net Income-$109.7M▼ 305.08% YoY

202320242025

FY 2025EPS$-46.00▼ 2400.00% YoY

202320242025

TTM:Revenue: $9.0MNet Income: -$56.0MEPS: $-26.80View income statement →

分析师评级与目标价

Buy2 位分析师

Strong Buy

0

Buy

2

Hold

0

Sell

0

Strong Sell

0

12-Month Price Target

$44.00Low

$17.42Current

$57.00Avg Target上涨空间 227.21%

$70.00High

合计: 2 · 买入占比: 100.0%

根据过去 3 个月内 2 位华尔街分析师，PRTC 共识评级为 Buy，12 个月平均目标价 $57.00 （较现价 $17.42 上涨空间 227.21%）。

竞争对手与同行

#TickerCompanyPriceChangeMkt Cap

PureTech Health plc

$17.42+0.99%$424.1M #2

ADC Therapeutics S.A.

$0.98-5.08%$124.4M #3

Alumis Inc. Common Stock

$18.99-0.37%$2.3B #4

Autolus Therapeutics plc

$1.46-4.58%$388.6M #5

Benitec Biopharma Inc.

$10.50-0.47%$275.6M #6

Lineage Cell Therapeutics, Inc.

$1.21+1.26%$301.7M

股票表现

1D+0.99%

1W+4.25%

1M+1.63%

3M+3.69%

YTD+4.69%

1Y-4.86%

5Y-68.95%

关于 PureTech Health plc

CEORobert Lyne

IPO DateNov 16, 2020

Employees80

CountryUS

Websitepuretechhealth.com

PureTech Health plc operates as a clinical-stage biotherapeutics company, dedicated to the discovery, advancement, and market introduction of innovative medicines. The firm's therapeutic focus spans a…

Biotechnology HealthcareNASDAQADRUS

关于股票概览与关键数据

PureTech Health plc（PRTC）是 Biotechnology 行业的 Healthcare 类公司，于 Nov 16, 2020 在 NASDAQ 上市。截至最近交易日，PRTC 股价为 $17.42，市值约为 $424.1M。过去12个月累计回报 -4.86%，年初至今回报 +4.69%。

根据 2 位华尔街分析师，PureTech Health plc 股票共识评级为Buy，12个月平均目标价为 $57.00。2025 财年 PureTech Health plc 营收 $4.7M，净利润 -$109.7M。更多数据（营收历史、盈利、股息、市盈率）请使用上方标签页。

常见问题

截至最近一个交易日，PureTech Health plc（PRTC）股价为 $17.42，在 NASDAQ 上市，52周区间为 $14.50 – $19.92。

PRTC 最新股价PRTC quote todaylive ticker 实时行情

数据来源：Financial Modeling Prep最后更新：Jun 9, 2026本内容不构成投资建议